4D Molecular Therapeutics Insider Sale: Director Kirn’s 10b‑5 Trade Is Routine, Not Red Flag
Insider sale by David Kirn signals routine liquidity planning, not panic, as 4D Molecular’s biotech outlook remains strong.
- 4D MOLECULAR THERAPEUTICS IN
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read